D
Do Young Kim
Researcher at Yonsei University
Publications - 737
Citations - 18320
Do Young Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 58, co-authored 674 publications receiving 15091 citations. Previous affiliations of Do Young Kim include University of Ulsan & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification
Seng Chan You,Kwang Joon Kim,Seung Up Kim,Beom Kyung Kim,Jun Yong Park,Do Young Kim,Sang Hoon Ahn,Kwang Hyub Han +7 more
TL;DR: This work investigated the association between coronary atherosclerosis and liver fibrosis, represented as coronary artery calcification score (CAC) score, and live stiffness value assessed using transient elastography (TE), respectively, in patients with NAFLD.
Journal ArticleDOI
Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
Hye Lim Ju,Sang Hoon Ahn,Do Young Kim,Sinhwa Baek,Sook In Chung,Jinsil Seong,Kwang Hyub Han,Simon Weonsang Ro +7 more
TL;DR: A simple methodology by which oncogenic cooperation between cancer-related genes can be efficiently investigated in the liver is reported by which firefly luciferase was co-expressed with the oncogenes as a reporter, allowing tumor growth in the Liver to be monitored over time without an invasive procedure.
Journal ArticleDOI
Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma.
TL;DR: The therapeutic benefit of radiotherapy (RT) in patients with huge unresectable HCCs is studied and the number of cases eligible for curative resection is limited.
Journal ArticleDOI
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway.
TL;DR: Recent advances in fields of liver fibrosis and carcinogenesis are reviewed, and emerging roles of the Hippo-YAP/TAZ signaling pathway in stromal activation, hepatic fibrosis, and liver cancer are considered.
Journal ArticleDOI
Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.
Hye Won Lee,Young Eun Chon,Seung Up Kim,Beom Kyung Kim,Jun Yong Park,Do Young Kim,Sang Hoon Ahn,Kyu Sik Jung,Young Nyun Park,Kwang Hyub Han +9 more
TL;DR: The LS value at SVR is useful for predicting LRE development in CHC patients who achieve SVR after treatment with peg-IFN plus ribavirin, and LRE surveillance strategies might be optimized according to the LS values at Svr, even with complete viral eradication.